MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41467-025-58327-y

Медицинская библиотека · Nature communications · 2025

Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China.

Jia Siyue, Liu Yuanbao, He Qian, Pan Hongxing, Liang Zhenglun, Zhou Juan, Pan Yingzi, Liu Sheng, Wu Jingjing, Yang Kun, Zhang Xuanxuan, Zhao Yang, Li Simin, Zhang Lei, Chen Li, Yao Aihua, Lu Mengyi, Zhu Fengcai, Mao Qunying, Li Jingxin

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПеревод в очереди

Аннотация

We conducted a multicenter, partially randomized, platform trial to assess the effectiveness of a booster dose of an aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine (Ad5-nCoV) in Chinese adults (NCT05855408). Between May 23, 2023, and August 28, 2023, 4089 eligible participants were equally randomized to receive either a booster dose of aerosolized Ad5-nCoV via oral inhalation at 0.1 mL (IH Ad5-nCoV, n = 2039) or an intramuscular injection of Ad5-nCoV at 0.5 mL (IM Ad5-nCoV, n = 2050). Additionally, 2008 participants who declined the booster but consented to participate in COVID-19 surveillance were enrolled in the control group. All participants were monitored for symptomatic COVID-19 over a six-month surveillance period for the primary outcome. From 14 days after the vaccination, 14 (15/1000 person-years), 19 (20/1000 person-years), and 34 (37/1000 person-years) COVID-19 cases were confirmed in the IH Ad5-nCoV group, the IM Ad5-nCoV group, and the control group, respectively, which resulted in an adjusted effectiveness of 52.3% (95% CI 10.4 to 74.6) for IH Ad5-nCoV and 37.2% (95% CI -11.2 to 64.5) for IM Ad5-nCoV. The IH Ad5-nCoV booster was associated with a lower incidence of symptomatic COVID-19, but there is no solid evidence that IH Ad5-nCoV was more effective than IM Ad5-nCoV.

Для цитирования: Jia Siyue, Liu Yuanbao, He Qian, Pan Hongxing, Liang Zhenglun, Zhou Juan, Pan Yingzi, Liu Sheng, Wu Jingjing, Yang Kun, Zhang Xuanxuan, Zhao Yang, Li Simin, Zhang Lei, Chen Li, Yao Aihua, Lu Mengyi, Zhu Fengcai, Mao Qunying, Li Jingxin. Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China.. Nature communications. 2025. DOI: 10.1038/s41467-025-58327-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.